Literature DB >> 23177631

Metabolic evaluation of first-time and recurrent stone formers.

David S Goldfarb1, Omotayo Arowojolu.   

Abstract

Evaluation of stone formers should include careful attention to medications, past medical history, social history, family history, dietary evaluation, occupation, and laboratory evaluation. Laboratory evaluation requires at least serum chemistries and urinalysis. Twenty-four-hour urine collections are most appropriate for patients with recurrent stones or complex medical histories. However, these collections may be appropriate for some first-time stone formers, including those with comorbidities or large stones. Although twin studies demonstrate that heritability accounts for at least 50% of the kidney stone phenotype, the responsible genes are not clearly identified, and so genetic testing is rarely indicated. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177631      PMCID: PMC4052537          DOI: 10.1016/j.ucl.2012.09.007

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  50 in total

Review 1.  Guidelines on urolithiasis.

Authors:  H G Tiselius; D Ackermann; P Alken; C Buck; P Conort; M Gallucci
Journal:  Eur Urol       Date:  2001-10       Impact factor: 20.096

2.  A woman with recurrent calcium phosphate kidney stones.

Authors:  David S Goldfarb
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 8.237

3.  The effect of fruits and vegetables on urinary stone risk factors.

Authors:  Tiziana Meschi; Umberto Maggiore; Enrico Fiaccadori; Tania Schianchi; Simone Bosi; Giuditta Adorni; Erminia Ridolo; Angela Guerra; Franca Allegri; Almerico Novarini; Loris Borghi
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

Review 4.  Metabolic syndrome and the genesis of uric acid stones.

Authors:  Naim M Maalouf
Journal:  J Ren Nutr       Date:  2011-01       Impact factor: 3.655

5.  Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date?

Authors:  David S Goldfarb
Journal:  Rev Urol       Date:  2002

6.  Beverage use and risk for kidney stones in women.

Authors:  G C Curhan; W C Willett; F E Speizer; M J Stampfer
Journal:  Ann Intern Med       Date:  1998-04-01       Impact factor: 25.391

7.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

Review 8.  Economics and cost of care of stone disease.

Authors:  Yair Lotan
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

9.  Demographic, dietary, and urinary factors and 24-h urinary calcium excretion.

Authors:  Eric N Taylor; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

10.  Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial.

Authors:  Antonio Nouvenne; Tiziana Meschi; Beatrice Prati; Angela Guerra; Franca Allegri; Giuseppe Vezzoli; Laura Soldati; Giovanni Gambaro; Umberto Maggiore; Loris Borghi
Journal:  Am J Clin Nutr       Date:  2009-12-30       Impact factor: 7.045

View more
  16 in total

Review 1.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

2.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

Review 3.  Updates in the Metabolic Management of Calcium Stones.

Authors:  Kristina L Penniston; Stephen Y Nakada
Journal:  Curr Urol Rep       Date:  2018-04-16       Impact factor: 3.092

4.  Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events.

Authors:  Michael G Selby; Terri J Vrtiska; Amy E Krambeck; Cynthia H McCollough; Hisham E Elsherbiny; Eric J Bergstralh; John C Lieske; Andrew D Rule
Journal:  Urology       Date:  2014-10-22       Impact factor: 2.649

Review 5.  Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.

Authors:  Helene Jung; Sero Andonian; Dean Assimos; Timothy Averch; Petrisor Geavlete; Yasuo Kohjimoto; Andreas Neisius; Joe Philip; Alberto Saita; Hemendra Shah; Palle Jörn Osther
Journal:  World J Urol       Date:  2017-02-03       Impact factor: 4.226

6.  UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.

Authors:  Naeem Bhojani; Jennifer Bjazevic; Brendan Wallace; Linda Lee; Kamaljot S Kaler; Marie Dion; Andrea Cowan; Nabil Sultan; Ben H Chew; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

7.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

8.  Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population.

Authors:  Yong Xu; Guohua Zeng; Zanlin Mai; Lili Ou
Journal:  Urolithiasis       Date:  2014-08-01       Impact factor: 3.436

9.  LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone.

Authors:  Martino Marangella; Michele Petrarulo; Corrado Vitale; Piergiuseppe Daniele; Silvio Sammartano
Journal:  Urolithiasis       Date:  2020-11-27       Impact factor: 3.436

10.  Outcomes and rates of dissolution therapy for uric acid stones.

Authors:  Jonathan Moore; Amihay Nevo; Saif Salih; Haidar Abdul-Muhsin; Mira Keddis; Karen Stern; Mitchell Humphreys
Journal:  J Nephrol       Date:  2021-06-25       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.